It is rare to see skin metastasis originated from the transitional cell carcinoma (TCC) of urinary tract. The incidence of skin metastasis from TCC of urinary bladder generally falls in the range from 0.2 to 2%, however, that of the TCC of renal pelvis metastasis to skin remains unknown. Most of the skin metastases occur at a time period from six months to several years after the diagnosis of the primary tumor. The treatment modalities adapted on the treatment of cutaneous metastasis include surgery, radiation therapy and chemotherapy with M-VAC (methrotrexate, vinblastin, adriamycin and cisplatin) or gemcitabine. We have seen a dismal prognosis on a male patient with skin metastasis from TCC of urinary tract.